Tumor mutational burden was 3.7 muts/Mb, microsatellite instability status was stable, and Programmed death ligand 1 (PD-L1) tumor proportion score (TPS) and combined positive score (CPS) were <1% and <1, respectively. Here, CD274 is linked to neoplasm.